Outbreak of Septic Arthritis Described in New Jersey

Share this content:
Outbreak of Septic Arthritis Described in New Jersey
Outbreak of Septic Arthritis Described in New Jersey

MONDAY, July 31, 2017 (HealthDay News) -- In a report published in the July 28 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report, details are presented of an outbreak of septic arthritis associated with intra-articular injections at a New Jersey outpatient practice.

Kathleen Ross, M.P.H., from the New Jersey Department of Health (NJDOH), and colleagues describe an outbreak of septic arthritis associated with intra-articular injections at an outpatient practice in New Jersey. On March 6, 2017, the NJDOH was notified of three cases of septic arthritis in patients who had received intra-articular injections for osteoarthritic knee pain.

The authors note that the NJDOH, together with the local health department and the New Jersey Board of Medical Examinations, identified 41 cases of septic arthritis associated with intra-articular injections administered during 250 patient visits at the same practice. Thirty of these cases were patients who required surgery. Bacterial cultures of synovial fluid or tissue were positive for 37 percent of patients; all recovered organisms were oral flora. Multiple breaches of recommended infection prevention practices were identified in an infection prevention assessment, including inadequate hand hygiene, inappropriate use of pharmacy bulk packaged (PBP) products as multiple-dose containers, handling of PBP products outside required pharmacy conditions, and syringe preparation up to four days before their intended use.

"The findings from this investigation highlight the need for better adherence to and oversight of basic infection prevention recommendations and sterile compounding standards in outpatient settings," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths